Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer

Lancet. 1976 Oct 9;2(7989):757-61. doi: 10.1016/s0140-6736(76)90598-5.

Abstract

Chimpanzees chronically infected with hepatitis-B virus showed transient changes in several markers of infection when treated with the interferon inducer polyriboinosinic-polyribocytidylic acid-poly-l-lysine carboxymethyl cellulose. Serum Dane-particle-associated D.N.A. polymerase, e antigen and hepatitis-B surface antigen, and intrahepatic hepatitis-B surface and core antigens diminished during treatment. Defective (D.N.A.-polymerase-negative) Dane particles increased in titre transiently during treatment; these may play a role in the modulation of hepatitis-B virus infection. Humoral immune responses in chronic hepatitis-B carrier chimps were unaffected. Interferon inducers (or exogenous interferon) may be useful for the treatment of chronic hepatitis-B virus infection.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Chronic Disease
  • Inclusion Bodies, Viral
  • Interferon Inducers / pharmacology*
  • Interferon Inducers / therapeutic use
  • Interferons / blood
  • Liver / immunology
  • Pan troglodytes
  • Poly I-C / analogs & derivatives*
  • Poly I-C / pharmacology

Substances

  • Interferon Inducers
  • Interferons
  • Poly I-C